Table 5.
Comparison of MAPSE and global strain values in patients treated and not treated by corticosteroids
| Group B (LGE + , LV EF ≥ 50%) n = 13 | Group C (LGE −, LV EF ≥ 50%) n = 30 | ||||||
|---|---|---|---|---|---|---|---|
| Corticosteroid-treated (n = 6) | No corticosteroids (n = 7) | p value | Corticosteroid-treated (n = 15) | No corticosteroids (n = 15) | p value | ||
| GLS (%) | − 19.15 ± 1.86 | − 19.14 ± 3.22 | 1.00 | − 20.95 ± 3.63 | − 23.32 ± 4.61 | 0.16 | |
| GCS (%) | − 26.51 ± 5.38 | − 23.36 ± 6.04 | 0.35 | − 25.19 ± 3.53 | − 27.74 ± 4.73 | 0.14 | |
| GRS (%) | 55.34 ± 10.69 | 46.26 ± 16.28 | 0.27 | 56.70 ± 16.75 | 63.80 ± 14.53 | 0.27 | |
| MAPSE (mm) | 10.83 ± 1.13 | 10.71 ± 1.93 | 0.90 | 11.23 ± 1.66 | 12.08 ± 1.90 | 0.22 | |
| MAPSE lateral (mm) | 11.00 ± 1.90 | 11.57 ± 2.51 | 0.66 | 12.40 ± 1.99 | 12.92 ± 2.56 | 0.55 | |
| MAPSE septal (mm) | 10.67 ± 1.21 | 9.86 ± 1.86 | 0.38 | 10.07 ± 1.53 | 11.23 ± 1.54 | 0.06 | |
Variables are expressed as the mean ± standard deviation
LGE +, positive late gadolinium enhancement; LGE–, negative late gadolinium enhancement; LV, left ventricle; EF, ejection fraction; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain; MAPSE, mitral annular plane systolic excursion